Category: Health Law

Robin Feldman on the Role of Trade Secrets in Shielding Pharmaceutical Pricing

Published on Author Jaime King

In “Naked Price and Trade Secret Overreach,” 22 Yale Journal of Law & Technology 61 (2020), Professor Robin Feldman and her co-author, Charles Tait Graves, draw critical attention to the ever-broadening assertion of trade secret protection as a device to obscure the price of healthcare goods and services. The article explores the danger of trade… Continue reading Robin Feldman on the Role of Trade Secrets in Shielding Pharmaceutical Pricing →

Jaime King on Challenges to State Attempts at Controlling Prescription Drug Costs

Published on Author Robin Feldman

 Professor Jaime King’s article, “The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs,” coauthored with Katherine Gudiksen and published in Journal of Legal Medicine, is a clear and cogent piece that adds to her distinguished scholarship on some of the most complex challenges facing the U.S. healthcare system. In the process,… Continue reading Jaime King on Challenges to State Attempts at Controlling Prescription Drug Costs →

Dorit Reiss and John Diamond on Liability for Anti-Vaccine Misinformation

Published on Author Scott Dodson

Vaccine laws and debates are spreading like a contagion. Measles, once thought nearly eradicated in the United States, has experienced outbreaks in Minnesota, New York, California, and other states. These outbreaks have been caused primarily by undervaccinated communities. The resurgency of measles and other vaccinable diseases has flamed the already virulent vaccination debates between public-health… Continue reading Dorit Reiss and John Diamond on Liability for Anti-Vaccine Misinformation →

Robin Feldman on High Drug Prices

Published on Author Jaime King

In trying to promote innovation and competition in pharmaceutical drugs, America has allowed the pharmaceutical industry to increase prices well beyond what other developed countries pay and the market should bear. While a majority of Americans say that prescription drugs have made their lives better in the last ten years, nearly 80% find the price… Continue reading Robin Feldman on High Drug Prices →

Jaime King on California’s Drug Transparency Law

Published on Author Robin Feldman

When Governor Jerry Brown signed California’s drug transparency law, Senate Bill 17 (SB-17), in 2017, the state took a crucial first step towards increased transparency and accountability in a landscape of skyrocketing prescription-drug prices. Not only does SB-17 require drug manufacturers and health insurers to disclose information about rising prescription-drug prices, but it also represents… Continue reading Jaime King on California’s Drug Transparency Law →

Jessica Vapnek on Packaged-Water Regulation

Published on Author Dave Owen

A few days ago, the New York Times ran an op-ed about the pervasive problems Pakistanis face accessing drinking water. Tap water is available in many places in Pakistan, but drinking it is a health risk; according to one recent report, forty percent of all deaths in Pakistan result from infectious diseases contracted by drinking… Continue reading Jessica Vapnek on Packaged-Water Regulation →

Dorit Reiss and Veena Dubal on Religious Accommodations for Vaccine Mandates in Employment

Published on Author Zach Price

What duty do healthcare employers have to accommodate employees with religious objections to influenza vaccines? My colleagues Dorit Reiss and Veena Dubal, recognized experts (respectively) in vaccine law and employment discrimination, have teamed up to provide an invaluable primer on the law governing this question. Their bottom-line answer is, “not much.” Professor Reiss and Professor… Continue reading Dorit Reiss and Veena Dubal on Religious Accommodations for Vaccine Mandates in Employment →

Robin Feldman on Drug Manufacturers’ Abuse of the Citizen-Petition Process

Published on Author Jaime King

Soaring healthcare prices currently threaten the viability of our healthcare system and the overall economy. U.S. healthcare spending, both per capita and as a percentage of GDP, far outpaces spending by any other high-income country, without corresponding increases in quality or access to care. Pharmaceutical drug prices, a component of overall healthcare spending, have dramatically… Continue reading Robin Feldman on Drug Manufacturers’ Abuse of the Citizen-Petition Process →

Jaime King on the Anti-Competitive Potential of Cross-Market Mergers in Health Care

Published on Author Robin Feldman

What drives health care costs ever higher? Consolidation may be playing a key role. In this context, Professor Jaime King’s contribution to the St. Louis University Annual Health Law Symposium, “The Anti-Competitive Potential of Cross-Market Mergers in Health Care” (coauthored with Erin C. Fuse Brown), is a clarion call for antitrust authorities to consider seriously… Continue reading Jaime King on the Anti-Competitive Potential of Cross-Market Mergers in Health Care →

Jaime King et al. on Freestanding Emergency Departments and the Healthcare Game

Published on Author Emily Murphy

The fragmented nature of the U.S. healthcare system creates many targets for criticism. Innovations such as freestanding emergency departments (EDs) have recently drawn fire from payers, policy makers, and professional organizations. In a new article in the Annals of Emergency Medicine titled “Don’t Hate the Player; Hate the Game,” Professor Jaime King (writing with physician… Continue reading Jaime King et al. on Freestanding Emergency Departments and the Healthcare Game →